Celonic is a Switzerland-based Contract Development and Manufacturing Organisation (CDMO) specialising in biologics. It partners with biotech companies worldwide to deliver innovative and efficient therapeutic solutions.

Celonic provides end-to-end services, from cell line development to commercial manufacturing, with expertise in monoclonal antibodies, bispecifics, and complex molecules. The company is recognised for adopting advanced bioprocessing technologies, such as process intensification, to make therapies more accessible.

Key Products and Services

• Drug substance development
• Preclinical, clinical, and late-phase supplies
• Advanced cell line systems (e.g., GS-CHOvolution®)
• Strategic alliances for fill and finish services

Celonic’s commitment to collaboration, agility, and cutting-edge technologies solidifies its reputation as a trusted partner in the biopharma sector.